Literature DB >> 6149589

Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.

J H Mendelson, N K Mello.   

Abstract

The reinforcing properties of delta 9THC (17.5 mg), a 1 g marijuana cigarette containing 1.83% delta 9-THC, a synthetic cannabis compound (Nabilone 2 mg orally), and their respective placebos were assessed with self-report and operant work-contingent choice procedures. Three groups of eight subjects were selected on the basis of a history of regular, intermittent, or occasional marijuana-smoking behavior. All subjects served as their own controls for each drug condition and studies were carried out under double-blind and "double-dummy" conditions in a controlled, residential research ward. Placebo responding did not vary as a function of history of marijuana use, but the past history of drug use had a significant influence on the reinforcing properties of cannabis compounds as well as the behavioral and physiological effects of these drugs. Regular marijuana users reported a significant increase in elation following marijuana smoking, but this was not associated with a significant increment in pulse rate. Intermittent and occasional marijuana smokers had significant increases in pulse rate, but no significant marijuana-induced elation. Nabilone and delta 9-THC produced a significant increase in pulse rate for all subject groups, but there was no significant increase in elation following ingestion of these compounds. Given a choice between the three drugs and three placebos, 18 of 23 subjects worked to obtain a marijuana cigarette in an operant work choice paradigm. These data indicate that smoked marijuana was significantly more reinforcing than all other cannabis compounds studied, regardless of past drug-use history.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149589     DOI: 10.1007/bf00428544

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Administration of marijuana to heavy and casual marijuana users.

Authors:  R E Meyer; R C Pillard; L M Shapiro; S M Mirin
Journal:  Am J Psychiatry       Date:  1971-08       Impact factor: 18.112

2.  Human polydrug use: marihuana and alcohol.

Authors:  N K Mello; J H Mendelson; J C Kuehnle; M L Sellers
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

3.  Nabilone: a potent antiemetic cannabinol with minimal euphoria.

Authors:  T S Herman; S E Jones; J Dean; S Leigh; R Dorr; T E Moon; S E Salmon
Journal:  Biomedicine       Date:  1977-12

4.  Evaluation of drug efficacy by a preference technic.

Authors:  H Jick; D Slone; B Dinan; H Muench
Journal:  N Engl J Med       Date:  1966-12-22       Impact factor: 91.245

5.  Clinical pharmacology of nabilone, a cannabinol derivative.

Authors:  L Lemberger; H Rowe
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

6.  Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.

Authors:  R R Griffiths; G E Bigelow; I Liebson; J E Kaliszak
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

7.  Comparison of effects of marihuana cigarettes to three different potencies.

Authors:  M Perez-Reyes; S Di Guiseppi; K H Davis; V H Schindler; C E Cook
Journal:  Clin Pharmacol Ther       Date:  1982-05       Impact factor: 6.875

8.  Drug preference and mood in humans: repeated assessment of d-amphetamine.

Authors:  C E Johanson; E H Uhlenhuth
Journal:  Pharmacol Biochem Behav       Date:  1981-02       Impact factor: 3.533

9.  Drug preference and mood in humans: d-amphetamine.

Authors:  C E Johanson; E H Uhlenhuth
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Drug preference and mood in humans: diazepam.

Authors:  C E Johanson; E H Uhlenhuth
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  18 in total

1.  Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.

Authors:  Joshua A Lile; Michael J Wesley; Thomas H Kelly; Lon R Hays
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

2.  Effects of acute marijuana smoking in post-menopausal women.

Authors:  R A Benedikt; P Cristofaro; J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2011-01-11       Impact factor: 4.492

4.  Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.

Authors:  Gillinder Bedi; Ziva D Cooper; Margaret Haney
Journal:  Addict Biol       Date:  2012-01-19       Impact factor: 4.280

5.  Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.

Authors:  Evan S Herrmann; Ziva D Cooper; Gillinder Bedi; Divya Ramesh; Stephanie C Reed; Sandra D Comer; Richard W Foltin; Margaret Haney
Journal:  Psychopharmacology (Berl)       Date:  2016-04-16       Impact factor: 4.530

Review 6.  Nabilone. A preliminary review of its pharmacological properties and therapeutic use.

Authors:  A Ward; B Holmes
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

Review 7.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

8.  Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.

Authors:  Margaret Haney; Ziva D Cooper; Gillinder Bedi; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  Neuropsychopharmacology       Date:  2013-02-26       Impact factor: 7.853

9.  Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.

Authors:  T H Kelly; R W Foltin; C S Emurian; M W Fischman
Journal:  J Exp Anal Behav       Date:  1994-03       Impact factor: 2.468

Review 10.  Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Addict Biol       Date:  2008-02-14       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.